Dr. Reddy’s Laboratories announces favorable outcome in patent litigation
Dr. Reddy’s Laboratories announced last week that the United States Court of Appeals for the Federal Circuit issued a decision in favor of Dr. Reddy’s Laboratories Inc., concluding that Indivior had not shown that it is likely to succeed on the merits of its infringement case on U.S. Patent